Skip to main content

GeneCluster, eGenome, Gene Construction Kit, IPI

Premium

The Cancer Genomics Group at the Whitehead Institute Center for Genome Research has released version 2.0 of its GeneCluster gene expression analysis application. The new release adds several features, including more options for pre-processing, marker selection, supervised classification, multiclass prediction, permutation test methods, and visualization.

GeneCluster 2.0 provides a gene marker selector based on neighborhood analysis, permutation tests, and visualization that allows users to view, sort, and color-code their data by keyword. It also includes tools for building supervised models using weighted voting and k-nearest neighbor algorithms. A beta version of the software, which can also be used for proteomic data, is available for free at www.genome.wi.mit.edu/cancer/software/software.html.

 

A beta version of eGenome — a position-based catalog of transcripts, markers, polymorphisms, large-insert clones, and DNA sequences for the human genome — is available from the Children’s Hospital of Philadelphia at http://egenome.chop.edu. A stable site with up-to-date content is expected to launch in July.

 

SciQuest of Research Triangle Park, NC, has released version 2.5 of its Gene Construction Kit, a DNA manipulation, cloning design, and illustration tool.

Enhancements in version 2.5 include a deluxe importer module that allows users to import GenBank and EMBL data and a customizable interface that converts GenBank and EMBL features to graphical GCK features. The software has also been ported to Mac OS X.

 

An IPI (International Protein Index) set is now available for mouse from the European Bioinformatics Institute at ftp://ftp.ebi.ac.uk/pub/databases/IPI/current.

The mouse IPI is a non-redundant protein set assembled from mouse sequences in Ensembl, SwissProt, Trembl, and RefSeq. Version 1.0 of the mouse IPI contains 30,517 sequences.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.